PL2696846T3 - Doustne dyspersyjne kompozycje farmaceutyczne - Google Patents

Doustne dyspersyjne kompozycje farmaceutyczne

Info

Publication number
PL2696846T3
PL2696846T3 PL11781582T PL11781582T PL2696846T3 PL 2696846 T3 PL2696846 T3 PL 2696846T3 PL 11781582 T PL11781582 T PL 11781582T PL 11781582 T PL11781582 T PL 11781582T PL 2696846 T3 PL2696846 T3 PL 2696846T3
Authority
PL
Poland
Prior art keywords
pharmaceutical compositions
dispersion pharmaceutical
oral dispersion
oral
compositions
Prior art date
Application number
PL11781582T
Other languages
English (en)
Inventor
Kurt Ingar Draget
Steinar Johan Engelsen
Tore Seternes
Magnus HATTREM
Ingvild Johanne Haug
Original Assignee
Vitux Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2011/000563 external-priority patent/WO2011128633A2/en
Application filed by Vitux Group As filed Critical Vitux Group As
Publication of PL2696846T3 publication Critical patent/PL2696846T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL11781582T 2011-04-11 2011-10-19 Doustne dyspersyjne kompozycje farmaceutyczne PL2696846T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/GB2011/000563 WO2011128633A2 (en) 2010-04-14 2011-04-11 Oral pharmaceutical dispersion compositions
PCT/GB2011/052027 WO2012140392A1 (en) 2011-04-11 2011-10-19 Oral pharmaceutical dispersion compositions
EP11781582.9A EP2696846B1 (en) 2011-04-11 2011-10-19 Oral pharmaceutical dispersion compositions

Publications (1)

Publication Number Publication Date
PL2696846T3 true PL2696846T3 (pl) 2018-06-29

Family

ID=44925573

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11781582T PL2696846T3 (pl) 2011-04-11 2011-10-19 Doustne dyspersyjne kompozycje farmaceutyczne

Country Status (6)

Country Link
EP (2) EP3178470A1 (pl)
JP (1) JP6067676B2 (pl)
CN (2) CN107875117A (pl)
CA (2) CA3023121A1 (pl)
PL (1) PL2696846T3 (pl)
WO (1) WO2012140392A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101288488B1 (ko) * 2011-05-25 2013-07-26 정국배 달력홀더 자동결합장치
WO2018175261A1 (en) 2017-03-20 2018-09-27 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
GB201916960D0 (en) * 2019-11-21 2020-01-08 Vitus Group As Compositions
GB202202754D0 (en) 2022-02-28 2022-04-13 Vitux Group As Compositions

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137630A (en) * 1961-06-09 1964-06-16 Eastman Kodak Co Process for preparing a dry, finely divided, gelatin particle product
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
US6482465B1 (en) * 1997-06-24 2002-11-19 Biovail Technologies Ltd. Positive hydration method of preparing confectionery and product therefrom
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6432442B1 (en) * 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
JP4221094B2 (ja) * 1998-11-25 2009-02-12 株式会社ニッピ 易嚥下補助組成物並びにそれを用いた食品用組成物及び医薬品用組成物
WO2002069936A2 (en) * 2001-03-02 2002-09-12 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition of ibuprofen
CN102600104B (zh) * 2002-04-25 2015-06-24 旗帜药物胶囊公司 可咀嚼的软胶囊
ES2355723T3 (es) * 2002-09-11 2011-03-30 Elan Pharma International Limited Composiciones de agente activo en nanopartículas estabilizadas en gel.
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
GB0317869D0 (en) * 2003-07-30 2003-09-03 Disperse Ltd Improved drug delivery system
JP2005187416A (ja) * 2003-12-26 2005-07-14 Lion Corp マイクロカプセル及びその製造方法
CA2604770C (en) * 2005-04-13 2013-09-24 Abbott Gmbh & Co. Kg Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
GB0601498D0 (en) 2006-01-25 2006-03-08 Probio Nutraceuticals As Product
CN101045041A (zh) * 2007-04-29 2007-10-03 武汉兵兵药业有限公司 含布洛芬的巴布剂及其制备方法和应用
GB0818473D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US20110224310A1 (en) * 2008-11-21 2011-09-15 Fujifilm Corporation Ceramide dispersion and method for producing same
GB0907019D0 (en) * 2009-04-24 2009-06-03 Oxford Nutrascience Ltd Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
US20130005740A1 (en) * 2009-08-05 2013-01-03 7267207 Canada Limited Corporation Process for preparation of over-the-counter gelatin or pectin-based drug delivery
GB201006214D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition

Also Published As

Publication number Publication date
CA2833105A1 (en) 2012-10-18
EP2696846B1 (en) 2018-01-17
CA3023121A1 (en) 2012-10-18
JP6067676B2 (ja) 2017-01-25
WO2012140392A1 (en) 2012-10-18
EP2696846A1 (en) 2014-02-19
CA2833105C (en) 2019-04-23
EP3178470A1 (en) 2017-06-14
CN103635178A (zh) 2014-03-12
JP2014510778A (ja) 2014-05-01
CN107875117A (zh) 2018-04-06

Similar Documents

Publication Publication Date Title
BR112014003052A2 (pt) composições farmacêuticas
SMT201600350B (it) Composizioni farmaceutiche
DK2694038T3 (da) Farmaceutisk sammensætning
CO6852076A2 (es) Composiciones farmacéuticas inhalables
SMT201700008B (it) Composizione farmaceutica
EP2760417A4 (en) Oral care compositions
CO6930367A2 (es) Composiciones farmaceúticas
LT2817000T (lt) Peroralinės dabigatrano eteksilato farmacinės kompozicijos
DK3284467T3 (da) Nikotinholdige farmaceutiske sammensætninger
DK3246018T3 (da) Farmaceutisk sammensætning
ZA201308208B (en) Pharmaceutical compositions
HUE040370T2 (hu) Gyógyszerkészítmények
BR112014006689A2 (pt) composição de cuidado oral
EE201300005A (et) Ravimkoostis
GT201200303A (es) Formulaciones farmacéuticas
DK2815752T3 (da) Oral farmaceutisk sammensætning
CO6801722A2 (es) Composiciones farmacéuticas
EP2769718A4 (en) MEDICAL COMPOSITION
BR112014015885A8 (pt) preparação farmacêutica
CO6801778A2 (es) Composiciones de cuidado oral
EP2732809A4 (en) ORAL COMPOSITION
EP2635307A4 (en) PHARMACEUTICAL COMPOSITIONS
GB201118181D0 (en) Pharmaceutical compositions
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
PL2696846T3 (pl) Doustne dyspersyjne kompozycje farmaceutyczne